Changeflow GovPing Healthcare FUJIFILM Medical Drug Recognition Device, Metho...
Routine Rule Added Final

FUJIFILM Medical Drug Recognition Device, Method, Program

Favicon for changeflow.com EPO Patent Bulletin - Health Informatics (G16H)
Published
Detected
Email

Summary

The European Patent Office granted Patent EP3603604A1 to FUJIFILM Medical Co., Ltd. for a drug recognition device, method, and program. The invention uses computer vision (G06V) and health informatics (G16H) technologies to identify and analyze drugs. The patent covers designated contracting states across the European Union.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

FUJIFILM Medical Co., Ltd. received European Patent EP3603604A1 for a drug recognition device, method, and program. The patent covers technology for identifying and analyzing pharmaceutical products using computer vision and image analysis techniques (IPC classes G06V, G16H, G01N).

Entities in the pharmaceutical and medical device manufacturing sectors may encounter this patent when developing drug identification or recognition systems. The patent grants FUJIFILM exclusive rights to the claimed drug recognition technology across designated European member states including Germany, France, Italy, Spain, and other EU contracting states.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DRUG RECOGNIZING DEVICE, DRUG RECOGNIZING METHOD, AND DRUG RECOGNIZING PROGRAM

Publication EP3603604A1 Kind: A1 Apr 08, 2026

Applicants

FUJIFILM Medical Co., Ltd.

Inventors

IWAMI, Kazuchika, TAKASHIMA, Masanobu

IPC Classifications

G06V 10/141 20220101AFI20250704BHEP G06V 10/772 20220101ALI20250704BHEP G06V 20/66 20220101ALI20250704BHEP G16H 20/13 20180101ALI20250704BHEP G16H 30/40 20180101ALI20250704BHEP G01N 21/95 20060101ALN20250704BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3603604A1

Who this affects

Applies to
Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant Drug recognition technology
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!